×
For best experience we recommend to activate Javascript in your browser.
NIFK antibody
The Mouse Monoclonal anti-NIFK antibody has been validated for WB. It is suitable to detect NIFK in samples from Human.
Quick Overview for NIFK antibody (ABIN6252517)
Target
See all NIFK (MKI67IP) Antibodies
NIFK (MKI67IP)
(MKI67 FHA Domain-Interacting Nucleolar Phosphoprotein (MKI67IP))
Reactivity
All reactivities for NIFK antibodies
Human
Host
All hosts for NIFK antibodies
Mouse
Clonality
All clonalities for NIFK antibodies
Monoclonal
Conjugate
All conjugates for NIFK antibodies
This NIFK antibody is un-conjugated
Application
All applications for NIFK antibodies
Western Blotting (WB)
Clone
NFK8436
Product Details anti-NIFK Antibody
(hide)
Purification
Protein G affinity chromatography
Immunogen
A recombinant protein fragment from the central portion of NIFK was used as the immunogen for this antibody.
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Western blot: 1-2 μg/mL Provided assay concentrations are suggestions only, antibody titration may be required for optimal results.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot and Store at -20C. Avoid freez-thaw cycles.
Target Details for NIFK
(hide)
Target
NIFK (MKI67IP)
(MKI67 FHA Domain-Interacting Nucleolar Phosphoprotein (MKI67IP))
Alternative Name
NIFK
Background
NIFK (nucleolar protein interacting with the FHA domain of pKi-67), also called Ki-67ip, was identified via a two-hybrid screening from HeLa cDNA using the N-terminal portion of pKi-67. It can bind RNA and may play a role in mitosis and cell cycle progression. In mitosis, NIFK is thought to colocalize with pKi-67 at the surface of mitotic chromosomes.
Gene ID
84365
UniProt
Q9BYG3
Recently viewed
(hide)
Chat with us , powered by LiveChat